EP3186257
Ný krómón oxím afleiða og notkun hennar sem hrifils hægs glútamatviðtaka
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.8.2015EP published:
6.2.2019EP application number:
15770814.0
EP translation filed:
12.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
26.8.2035Expiry date:
26.8.2021
Title:
NOVEL CHROMONE OXIME DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS
Timeline
Today
27.8.2015EP application
6.2.2019EP Publication
12.3.2019Translation submitted
15.4.2019Registration published
26.8.2021Expires
Owner
Name:
Prexton Therapeutics SAAddress:
14 Chemin des Aulx, 1228, Plan les Ouates, Geneva, CH
Inventor
Name:
CHARVIN, DelphineAddress:
Gex, FR
Name:
MANTEAU, BaptisteAddress:
Lingolsheim, FR
Name:
POMEL, VincentAddress:
Groisy, FR
Name:
CONQUET, FrançoisAddress:
Beaumont, FR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
14182468Date:
27.8.2014Country:
EP
Classification
Categories:
C07D 495/04, A61K 31/407, A61P 25/16
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 9.7.2019
Expires: 26.8.2020
Payer: Árnason Faktor
Number: 6
Paid: 8.7.2020
Expires: 26.8.2021
Payer: Árnason Faktor ehf.